AGRX Annual Operating Profit
-$19.88 M
+$21.55 M+52.01%
31 December 2023
Summary:
As of February 5, 2025, AGRX annual operaing income is -$19.88 million, with the most recent change of +$21.55 million (+52.01%) on December 31, 2023. During the last 3 years, it has risen by +$29.17 million (+59.46%).AGRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGRX Quarterly Operating Profit
-$2.75 M
+$11.00 K+0.40%
01 June 2024
Summary:
As of February 5, 2025, AGRX quarterly operating income is -$2.75 million, with the most recent change of +$11.00 thousand (+0.40%) on June 1, 2024. Over the past year, it has increased by +$2.38 million (+46.43%).AGRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGRX TTM Operating Profit
-$13.55 M
+$2.38 M+14.94%
01 June 2024
Summary:
As of February 5, 2025, AGRX TTM operating income is -$13.55 million, with the most recent change of +$2.38 million (+14.94%) on June 1, 2024. Over the past year, it has increased by +$12.74 million (+48.46%).AGRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGRX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +52.0% | +46.4% | +48.5% |
| 3 y3 years | +59.5% | +83.5% | +78.9% |
| 5 y5 years | -7.4% | +22.6% | +28.1% |
AGRX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +56.2% | +42.3% | +220.6% |
Agile Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$2.75 M(-0.4%) | -$13.55 M(-14.9%) |
| Mar 2024 | - | -$2.76 M(-32.0%) | -$15.94 M(-19.9%) |
| Dec 2023 | -$19.88 M(-52.0%) | -$4.05 M(+1.3%) | -$19.89 M(-12.4%) |
| Sept 2023 | - | -$4.00 M(-22.0%) | -$22.71 M(-13.6%) |
| June 2023 | - | -$5.13 M(-23.6%) | -$26.30 M(-19.3%) |
| Mar 2023 | - | -$6.71 M(-2.5%) | -$32.57 M(-21.4%) |
| Dec 2022 | -$41.43 M(-41.6%) | -$6.88 M(-9.3%) | -$41.44 M(-27.2%) |
| Sept 2022 | - | -$7.59 M(-33.4%) | -$56.91 M(-12.6%) |
| June 2022 | - | -$11.40 M(-26.8%) | -$65.10 M(-7.5%) |
| Mar 2022 | - | -$15.57 M(-30.3%) | -$70.36 M(-0.9%) |
| Dec 2021 | -$71.00 M(+44.8%) | -$22.36 M(+41.7%) | -$71.00 M(+8.6%) |
| Sept 2021 | - | -$15.77 M(-5.3%) | -$65.39 M(+1.7%) |
| June 2021 | - | -$16.65 M(+2.6%) | -$64.27 M(+11.5%) |
| Mar 2021 | - | -$16.22 M(-3.1%) | -$57.66 M(+17.5%) |
| Dec 2020 | -$49.05 M(+160.1%) | -$16.74 M(+14.2%) | -$49.05 M(+27.7%) |
| Sept 2020 | - | -$14.66 M(+46.0%) | -$38.42 M(+35.9%) |
| June 2020 | - | -$10.04 M(+31.8%) | -$28.26 M(+29.8%) |
| Mar 2020 | - | -$7.62 M(+24.8%) | -$21.77 M(+15.4%) |
| Dec 2019 | -$18.86 M(+1.8%) | -$6.11 M(+35.7%) | -$18.86 M(+16.6%) |
| Sept 2019 | - | -$4.50 M(+26.8%) | -$16.18 M(+7.9%) |
| June 2019 | - | -$3.55 M(-24.6%) | -$14.99 M(-7.3%) |
| Mar 2019 | - | -$4.71 M(+37.6%) | -$16.18 M(-12.6%) |
| Dec 2018 | -$18.52 M | -$3.42 M(+3.2%) | -$18.52 M(-12.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$3.32 M(-29.9%) | -$21.08 M(-13.8%) |
| June 2018 | - | -$4.73 M(-32.9%) | -$24.46 M(-8.5%) |
| Mar 2018 | - | -$7.05 M(+17.7%) | -$26.73 M(-0.3%) |
| Dec 2017 | -$26.81 M(-9.8%) | -$5.99 M(-10.7%) | -$26.81 M(-6.4%) |
| Sept 2017 | - | -$6.70 M(-4.2%) | -$28.63 M(-1.3%) |
| June 2017 | - | -$7.00 M(-1.8%) | -$29.02 M(-2.8%) |
| Mar 2017 | - | -$7.13 M(-8.7%) | -$29.87 M(+0.5%) |
| Dec 2016 | -$29.72 M(-10.2%) | -$7.81 M(+10.1%) | -$29.72 M(-4.4%) |
| Sept 2016 | - | -$7.09 M(-9.6%) | -$31.08 M(-5.7%) |
| June 2016 | - | -$7.84 M(+12.3%) | -$32.95 M(-0.4%) |
| Mar 2016 | - | -$6.98 M(-23.8%) | -$33.09 M(+0.0%) |
| Dec 2015 | -$33.09 M(+78.7%) | -$9.16 M(+2.2%) | -$33.09 M(+8.7%) |
| Sept 2015 | - | -$8.96 M(+12.3%) | -$30.45 M(+10.6%) |
| June 2015 | - | -$7.98 M(+14.4%) | -$27.53 M(+19.5%) |
| Mar 2015 | - | -$6.98 M(+6.9%) | -$23.04 M(+24.5%) |
| Dec 2014 | -$18.52 M(+45.5%) | -$6.52 M(+7.9%) | -$18.52 M(+33.0%) |
| Sept 2014 | - | -$6.05 M(+73.1%) | -$13.92 M(+24.4%) |
| June 2014 | - | -$3.49 M(+42.8%) | -$11.19 M(+2.2%) |
| Mar 2014 | - | -$2.45 M(+26.9%) | -$10.95 M(-14.0%) |
| Dec 2013 | -$12.73 M(-45.4%) | -$1.93 M(-41.9%) | -$12.73 M(+17.9%) |
| Sept 2013 | - | -$3.32 M(+2.2%) | -$10.80 M(+44.4%) |
| June 2013 | - | -$3.25 M(-23.2%) | -$7.48 M(+76.8%) |
| Mar 2013 | - | -$4.23 M | -$4.23 M |
| Dec 2012 | -$23.32 M | - | - |
FAQ
- What is Agile Therapeutics annual operaing income?
- What is the all time high annual operating profit for Agile Therapeutics?
- What is Agile Therapeutics annual operating profit year-on-year change?
- What is Agile Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Agile Therapeutics?
- What is Agile Therapeutics quarterly operating profit year-on-year change?
- What is Agile Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Agile Therapeutics?
- What is Agile Therapeutics TTM operating profit year-on-year change?
What is Agile Therapeutics annual operaing income?
The current annual operating profit of AGRX is -$19.88 M
What is the all time high annual operating profit for Agile Therapeutics?
Agile Therapeutics all-time high annual operaing income is -$12.73 M
What is Agile Therapeutics annual operating profit year-on-year change?
Over the past year, AGRX annual operaing income has changed by +$21.55 M (+52.01%)
What is Agile Therapeutics quarterly operating income?
The current quarterly operating profit of AGRX is -$2.75 M
What is the all time high quarterly operating profit for Agile Therapeutics?
Agile Therapeutics all-time high quarterly operating income is -$1.93 M
What is Agile Therapeutics quarterly operating profit year-on-year change?
Over the past year, AGRX quarterly operating income has changed by +$2.38 M (+46.43%)
What is Agile Therapeutics TTM operating income?
The current TTM operating profit of AGRX is -$13.55 M
What is the all time high TTM operating profit for Agile Therapeutics?
Agile Therapeutics all-time high TTM operating income is -$4.23 M
What is Agile Therapeutics TTM operating profit year-on-year change?
Over the past year, AGRX TTM operating income has changed by +$12.74 M (+48.46%)